Piramal Pharma has given a breakout @101.10 after clearing resistance at 97.30 on nearly double the volume of 10 days average volumes. The first target is 125.20 followed by second target of 145.80 and final target of 180. Stop loss for the trade should be below 87.50.
Piramal Pharma was demerged from Piramal Enterprise and after opening at 200 it had gone down to 63 during Feb '23.
Disclosure: This analysis is done only for Education purposes, and should consult financial advisor before undertaking trade.
Piramal Pharma was demerged from Piramal Enterprise and after opening at 200 it had gone down to 63 during Feb '23.
Disclosure: This analysis is done only for Education purposes, and should consult financial advisor before undertaking trade.
C_Nandlal
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.
C_Nandlal
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.